Actelion   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Allschwill Switzerland (1997)
Status: Acquired by Johnson and Johnson (2017)

Organization Overview

First Clinical Trial
2002
NCT00517153
First Marketed Drug
2001
bosentan (tracleer)
First NDA Approval
2001
bosentan (tracleer)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Actelion | ACTELION | Actelion Japan | Actelion Pharmaceuticals Australia Pty. Ltd | Actelion Pharmaceuticals Limited | Actelion Pharmaceuticals U.S., Inc. | Actelion Pharmaceuticals US, Inc | Actelion Pharmaceuticals US, Inc. | ACTELION PHARMS | ACTELION PHARMS LTD